News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Daily News FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention Shelley Wood June 01, 2020
Podcast Rox Heart Radio Rox Heart Radio: ‘Getting to Know You’ With P. Gabriel Steg November 14, 2019
Presentation TCT 2014 EUROMAX and HORIZONS-AMI: Core Results and Study Group Interpretation Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Philippe Gabriel Steg September 13, 2014